Padua Prediction Score for VTE Risk in Thoracic Surgery Patients
DVT
Assessment of the Padua Prediction Score for Venous Thromboembolism Risk Stratification in Thoracic Surgery Patients: Insights From a Single-Center Cohort Study in Iraq
2 other identifiers
observational
150
1 country
1
Brief Summary
The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients. The study aims to answer the following question: Does the PPS provide a more accurate prediction of VTE risk? Participants will: Have their VTE risk assessed using the PPS during their hospital admission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 10, 2024
CompletedFirst Posted
Study publicly available on registry
December 13, 2024
CompletedStudy Start
First participant enrolled
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 15, 2025
CompletedMarch 18, 2025
March 1, 2025
2 months
December 10, 2024
March 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incidence of Venous Thromboembolism (VTE) Episodes in Patients
symptomatic or asymptomatic, confirmed by instrumental diagnostics.
In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 30
Padua Prediction Score
A total score that ranges from 0 to 20. 4 or higher indicates a significant likelihood of developing VTE.
Day 1 preoperative (one day prior to surgery)
Secondary Outcomes (2)
Incidence of Symptomatic Pulmonary Embolism in Patients
In-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 30
Rate of Recurrent Deep Vein Thrombosis (DVT) in Patients
Post-Discharge Follow-Up: Day 7, Day 15, and Day 30
Eligibility Criteria
The study will focus on adult patients undergoing thoracic surgery at a single center in Iraq.
You may qualify if:
- Patients who have undergone preoperative Padua Prediction Score assessment.
- Inpatients with a hospital stay over 3 days
- Written informed consent obtained from patients or their legal guardians.
- Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.
You may not qualify if:
- Preexisting LEVT or pulmonary embolism.
- Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease).
- receiving any anticoagulation therapy for any reason.
- patients who did not undergo a postoperative D-dimer test.
- Incomplete Data: missing essential clinical or laboratory data.
- Pregnancy: pregnant women or those within six weeks postpartum.
- Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
College of Medicine - Al-Nahrain University
Baghdad, Kadhimiya, Iraq
Related Publications (2)
Al Yami MS, Silva MA, Donovan JL, Kanaan AO. Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis. J Thromb Thrombolysis. 2018 Jan;45(1):36-47. doi: 10.1007/s11239-017-1562-5.
PMID: 29043538BACKGROUNDBarbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010 Nov;8(11):2450-7. doi: 10.1111/j.1538-7836.2010.04044.x.
PMID: 20738765RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yaser aamer Eisa Alhaibi, Assistant professor
College Of Medicine - Nahrain University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 10, 2024
First Posted
December 13, 2024
Study Start
April 20, 2025
Primary Completion
July 1, 2025
Study Completion
July 15, 2025
Last Updated
March 18, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share